Visa (NYSE:V) announced today that it has appointed Andrew Torre, a 20-year Visa veteran, as President of Value-Added Services (VAS). Mr. Torre will replace Antony Cahill who was recently named Regional President and Chief Executive Officer for Visa’s European operations, subject to regulatory approval. Mr. Torre will report to Visa Chief Executive Officer Ryan McInerney and join the Company’s global leadership team. He will be based in San Francisco and take on this role effecti...

BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will share data across a range of hematologic malignancies at the European Hematology Association (EHA) Congress in Milan, Italy, June 12–15. BeiGene has 31 abstracts accepted at EHA 2025, with four selected for oral presentations, featuring data from its best-in-class Bruton’s tyrosine kinase (BTK) inhibitor BRUKINSA® (zanubrutinib) and its inve...